Frank JASCHINSKI

Person

Puchheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
ANGPTL4 oligonucleotides influencing the regulation of the fatty ac...
- Patent number 12,024,708
- Issue date Jul 2, 2024
- Lipigon Pharmaceuticals AB
- Frank Jaschinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunosuppression-reverting oligonucleotides inhibiting the express...
- Patent number 11,959,083
- Issue date Apr 16, 2024
- Secarna Pharmaceuticals GmbH & Co. KG
- Frank Jaschinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide inhibiting the expression of Chop
- Patent number 11,781,136
- Issue date Oct 10, 2023
- Secarna Pharmaceuticals GmbH & Co. KG
- Richard Klar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ANGPTL4 oligonucleotides influencing the regulation of the fatty ac...
- Patent number 11,781,139
- Issue date Oct 10, 2023
- Lipigon Pharmaceuticals AB
- Frank Jaschinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for inhibition of PD-L1 expression and t...
- Patent number 11,666,595
- Issue date Jun 6, 2023
- Secarna Pharmaceuticals GmbH & Co. KG
- Tamara Thelemann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Approach for treating inflammatory disorders
- Patent number 10,647,987
- Issue date May 12, 2020
- Secama Pharmaceuticals GmbH & Co KG
- Frank Jaschinski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY AC...
- Publication number 20240384272
- Publication date Nov 21, 2024
- Lipigon Pharmaceuticals AB
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein...
- Publication number 20240076673
- Publication date Mar 7, 2024
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligonucleotide for reducing the expression of angiotensin-converti...
- Publication number 20240067973
- Publication date Feb 29, 2024
- The First Affiliated Hospital of Sun Yat-sen University
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PD-1-specific antisense oligonucleotide and its use in therapy
- Publication number 20230183708
- Publication date Jun 15, 2023
- Secarna Pharmaceuticals GmbH & Co KG
- Richard KLAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of metadherin expression
- Publication number 20230067620
- Publication date Mar 2, 2023
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified antisense oligonucleotide for inhibition of FoxP3 expression
- Publication number 20220372482
- Publication date Nov 24, 2022
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligonucleotide based ex vivo cell therapy
- Publication number 20220372479
- Publication date Nov 24, 2022
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-L1 antisense oligonucleotides for use in tumor treatment
- Publication number 20220220485
- Publication date Jul 14, 2022
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY AC...
- Publication number 20220162613
- Publication date May 26, 2022
- Lipigon Pharmaceuticals AB
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY AC...
- Publication number 20220010311
- Publication date Jan 13, 2022
- Lipigon Pharmaceuticals AB
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF CHOP
- Publication number 20200283764
- Publication date Sep 10, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Richard KLAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immunosuppression-Reverting Oligonucleotides Inhibiting the Express...
- Publication number 20200224202
- Publication date Jul 16, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immunosuppression-Reverting Oligonucleotides Inhibiting the Express...
- Publication number 20200163988
- Publication date May 28, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Richard KLAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel Approach for Treating Cancer
- Publication number 20200009181
- Publication date Jan 9, 2020
- Secarna Pharmaceuticals GmbH & Co KG
- Tamara HILMENYUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDES INHIBITING THE EXPRESSION OF NRP1
- Publication number 20190330640
- Publication date Oct 31, 2019
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL APPROACH FOR TREATING INFLAMMATORY DISORDERS
- Publication number 20190055566
- Publication date Feb 21, 2019
- Secarna Pharmaceuticals GmbH & Co KG
- Frank JASCHINSKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Frank JASCHINSKI

Person

Patents Grantslast 30 patents

ANGPTL4 oligonucleotides influencing the regulation of the fatty ac...

Immunosuppression-reverting oligonucleotides inhibiting the express...

Oligonucleotide inhibiting the expression of Chop

ANGPTL4 oligonucleotides influencing the regulation of the fatty ac...

Antisense oligonucleotides for inhibition of PD-L1 expression and t...

Approach for treating inflammatory disorders

Patents Applicationslast 30 patents

ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY AC...

Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein...

Oligonucleotide for reducing the expression of angiotensin-converti...

PD-1-specific antisense oligonucleotide and its use in therapy

Inhibitor of metadherin expression

Modified antisense oligonucleotide for inhibition of FoxP3 expression

Oligonucleotide based ex vivo cell therapy

PD-L1 antisense oligonucleotides for use in tumor treatment

ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY AC...

ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY AC...

OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF CHOP

Immunosuppression-Reverting Oligonucleotides Inhibiting the Express...

Immunosuppression-Reverting Oligonucleotides Inhibiting the Express...

Novel Approach for Treating Cancer

OLIGONUCLEOTIDES INHIBITING THE EXPRESSION OF NRP1

NOVEL APPROACH FOR TREATING INFLAMMATORY DISORDERS